No results found Access to treatment, Policy and EU affairs Web Team 08/10/2026 Access to treatment, Policy and EU affairs Web Team 08/10/2026 New European report calls for faster access to cancer research and care Read More Access to treatment, Policy and EU affairs Web Team 30/09/2026 Access to treatment, Policy and EU affairs Web Team 30/09/2026 Advocating for more inclusive clinical trials across Europe Read More Treatment and research Web Team 01/07/2026 Treatment and research Web Team 01/07/2026 HARMONi-7: European sites now open for Phase 3 ivonescimab trial in high PD-L1 NSCLC Read More Access to treatment, Policy and EU affairs Web Team 30/06/2026 Access to treatment, Policy and EU affairs Web Team 30/06/2026 EU Progress on 2030 Clinical Trial Targets: What It Means for Lung Cancer Read More Access to treatment, Policy and EU affairs Web Team 16/05/2026 Access to treatment, Policy and EU affairs Web Team 16/05/2026 Why people with lung cancer in Europe are being left behind on clinical trials Read More
Access to treatment, Policy and EU affairs Web Team 08/10/2026 Access to treatment, Policy and EU affairs Web Team 08/10/2026 New European report calls for faster access to cancer research and care Read More
Access to treatment, Policy and EU affairs Web Team 30/09/2026 Access to treatment, Policy and EU affairs Web Team 30/09/2026 Advocating for more inclusive clinical trials across Europe Read More
Treatment and research Web Team 01/07/2026 Treatment and research Web Team 01/07/2026 HARMONi-7: European sites now open for Phase 3 ivonescimab trial in high PD-L1 NSCLC Read More
Access to treatment, Policy and EU affairs Web Team 30/06/2026 Access to treatment, Policy and EU affairs Web Team 30/06/2026 EU Progress on 2030 Clinical Trial Targets: What It Means for Lung Cancer Read More
Access to treatment, Policy and EU affairs Web Team 16/05/2026 Access to treatment, Policy and EU affairs Web Team 16/05/2026 Why people with lung cancer in Europe are being left behind on clinical trials Read More
